US · Healthcare

Regeneron Pharmaceuticals Inc (REGN)

Biotechnology

Regeneron Pharmaceuticals Inc (REGN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for REGN

P/E ratio

18.00

Regeneron Pharmaceuticals Inc (REGN) — FAQ

What is REGN's P/E ratio?

The price-to-earnings (P/E) ratio for Regeneron Pharmaceuticals Inc (REGN) is 18.00 (data as of 2026-03-24).

Does Regeneron Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Regeneron Pharmaceuticals Inc (REGN). Check the MyAverix Finance app for the latest dividend data.

What sector is Regeneron Pharmaceuticals Inc in?

Regeneron Pharmaceuticals Inc (REGN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is REGN listed on?

REGN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)